Autoleucel (Relmacabtagene Autoleucel) Clinical Trials

1 actively recruiting trial

Also known as: Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Pipeline

Phase 2: 1

Top Sponsors

Sun Yat-sen University1

Indications

Follicular Lymphoma ( FL)1
Mantle Cell Lymphoma (MCL)1
Large B Cell Diffuse Lymphoma1
Cancer1

Other1 trial

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.